Relationships in Good Hands - Clinical and Cost-effectiveness of Dyadic Developmental Psychotherapy
Launched by UNIVERSITY OF GLASGOW · Dec 3, 2019
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Relationships in Good Hands," is studying a type of therapy called Dyadic Developmental Psychotherapy (DDP) to see if it can help improve the mental health of fostered and adopted children aged 5 to 12 who are facing various challenges, such as ADHD and relationship problems. The trial aims to understand not only if DDP is effective but also if the commitment it requires from families—about 20 sessions over six months—is worth the effort and cost. The research will take place in different settings, like the NHS and private practices, to determine how well DDP can be integrated into existing services for children who have experienced abuse or neglect.
To participate in the trial, families must be adoptive or permanent foster parents with children showing symptoms of mental health issues. However, if therapists feel that a family isn’t ready for DDP or if the child is currently receiving other therapy, they may not be eligible. Participants can expect to be part of a supportive research environment where their experiences will help shape future services for vulnerable children. Ultimately, if DDP proves to be beneficial, it could lead to better mental health support for abused and neglected children both in the UK and around the world.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Adoptive or permanent foster parents with children aged 5-12 years with symptoms of MAPP or co-occurring mental health conditions and non-psychotherapeutic treatments
- Exclusion Criteria:
- • Families, otherwise eligible, deemed by therapists as not ready for DDP (usually where therapists have concerns about the ability of carers/parents to create a safe/ nurturing enough environment within which DDP can operate)
- • Children currently having another psychotherapy
About University Of Glasgow
The University of Glasgow is a prestigious academic institution renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of medicine and health sciences to design and conduct innovative clinical trials. With a strong focus on ethical standards and patient safety, the University of Glasgow collaborates with multidisciplinary teams and partners to translate research findings into practical applications, fostering advancements in medical knowledge and therapeutic interventions. Its dedication to excellence in research and education positions the university as a leader in clinical trial initiatives that aim to address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Norwich, , United Kingdom
Lanark, Scotland, United Kingdom
Barry, , United Kingdom
Bedford, , United Kingdom
Birmingham, , United Kingdom
Bradford, , United Kingdom
Doncaster, , United Kingdom
Ebbw Vale, , United Kingdom
Norwich, , United Kingdom
Nottingham, , United Kingdom
Nottingham, , United Kingdom
Oxford, , United Kingdom
Shefford, , United Kingdom
Stevenage, , United Kingdom
Wolverhampton, , United Kingdom
Patients applied
Trial Officials
Helen Minnis, Professor
Principal Investigator
University of Glasgow
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials